Clinical Trials Sponsored by HAL Allergy

Total 5938 results

Allergan

Completed

Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale

Erythema | Rosacea

United States
Allergan

Completed

Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.

Skin Care

United States
Allergan

Completed

Evaluation of Eflornithine on Facial and Forearm Skin

Hirsutism
Allergan

Completed

Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults

Lip Enhancement

China
Allergan

Completed

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Diabetes Mellitus | Gastroparesis | Diabetes Mellitus Complications

United States, United Kingdom, Belgium, Israel, Germany, Poland, Sweden
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Lateral Canthal Lines | Crow's Feet Lines

Korea, Republic of
Allergan

Completed

Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Conjunctivitis, Allergic

Korea, Republic of
Allergan

Completed

Optive Brand For Day And Night Dry Eye Management

Dry Eye

United Kingdom
Allergan

Completed

A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas

Uterine Hemorrhage | Leiomyoma

United States, Canada
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

Crow's Feet Lines | Lateral Canthus Rhytides

Belgium, Canada, United States, United Kingdom
Allergan

Completed

Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women

Health

United States
Allergan

Completed

A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Overactive Bladder

Poland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
Allergan

Completed

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
Allergan

Completed

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Uterine Hemorrhage | Leiomyoma

United States
Allergan

Completed

A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement

Subjects Desiring Lip Augmentation

United States
Allergan

Completed

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

Dry Eye Disease

United States
Allergan

Completed

Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema

Diabetic Macular Edema

Canada, United States
Allergan

Completed

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Diabetic Macular Edema | Vitrectomy

United States, Australia
Allergan

Completed

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Overactive Bladder | Urinary Incontinence

Poland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
Allergan

Completed

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Macular Edema | Retinal Vein Occlusion

Germany
Allergan

Completed

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (IMPACT)

Dry Eye Syndromes

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

Glaucoma, Open-Angle

Spain, Portugal
Allergan

Completed

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Macular Edema | Retinal Vein Occlusion

United States
Allergan

Completed

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Conjunctivitis, Allergic

Japan
Allergan

Completed

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

Alopecia Areata | Eyelash Hypotrichosis

United States, Brazil
Allergan

Completed

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Macular Edema

France, Spain, Belgium, United States, South Africa, Denmark, Netherlands, Israel, Portugal, United Kingdom, Italy, Germany
Allergan

Completed

Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)

Macular Edema

China
Allergan

Completed

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Facial Rhytides

Canada
Allergan

Completed

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

China
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Refresh Contacts®

Contact Lens Lubrication

United States
Allergan

Completed

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Crow's Feet Lines | Lateral Canthus Rhytides

Japan
Allergan

Completed

Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® (PREDICT)

Migraine Disorders

Canada
Allergan

Completed

Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines

Glabellar Lines

Germany
Allergan

Completed

Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

Diabetic Macular Oedema

Australia
Allergan

Completed

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Migraine, With or Without Aura

United States
Allergan

Completed

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (PINE)

Macular Degeneration

Japan
Allergan

Terminated

Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing

Temple Hollowing

United States
Allergan

Terminated

Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

Osteomyelitis

United States
Allergan

Completed

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Spain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
Allergan

Completed

Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)

Glaucoma, Open-Angle | Normal Tension Glaucoma

Korea, Republic of
Allergan

Completed

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Macular Degeneration

United States
Allergan

Completed

Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its Metabolites

Hepatic Impairment

United States
Allergan

Completed

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome

Cystitis, Interstitial | Painful Bladder Syndrome

United States, Canada
Allergan

Completed

A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults

Nasolabial Fold

China
Allergan

Completed

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Facial Rhytides | Glabellar Rhytides

United States, Belgium, Germany, United Kingdom
Allergan

Completed

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis® (EMPOWER)

Dry Eye Syndromes

United States

3

Subscribe